久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Featured Contributors

How moneyed interests spawned and sustained US opioid crisis

By Xu Ying | chinadaily.com.cn | Updated: 2023-10-16 10:31
Share
Share - WeChat
Cai Meng | China Daily

The opioid epidemic ravaging communities across America represents a profound public health crisis and moral failing decades in the making. This unfolding tragedy spotlights how profit motives and regulatory lapses incubated a contagion of addiction that enriched drug makers while extracting a ghastly human toll. Behind the statistics lie broken lives and betrayed trust.

The sheer scale of opioid mortality remains shocking despite growing awareness and mitigation efforts. With over 100,000 deaths in 2021 alone, opioid overdoses claimed more American lives yearly than car crashes or gun violence. And the crisis is worsening, with synthetic opioids like fentanyl causing record spikes in fatalities by permeating illicit drug supplies. This exponential loss of life now exceeds the darkest years of the AIDS epidemic.

Rather than a public health disaster happening organically, the opioid crisis was manufactured through calculated choices to drive addiction for profit. The relentless promotion of OxyContin as a low-risk analgesic directly seeded today's landscape littered with fatalities. Despite knowing the enormous dependency risks, the Sackler family deployed false marketing to push their blockbuster pill, raking in over $35 billion from Oxy sales since the 1990s.

The medical establishment shares culpability for becoming complicit conduits enabling mass over-prescription. Professional associations funded by opioid makers popularized the myth that doctors were under-treating chronic pain, abandoning caution about addictive risks. Misleading assertions that dependency was rare if opioids were properly prescribed for pain became common, despite contrary evidence. With incentives skewed, restraint was abandoned as doctors followed loosened guidelines.

Lax oversight from captured regulators like the FDA and DEA also facilitated the pharmaceutical free-for-all. Despite clear warnings about addiction and diversion, agencies succumbed to fierce industry lobbying to permit aggressive opioid marketing and distribution. Their regulatory surrender allowed and even abetted the ensuing epidemic rather than blocking it. This abdication of duty left Americans unprotected.

With profit seeking unconstrained and oversight neutered, conditions ripened for catastrophe on a national scale. The result after two decades was a historic public health crisis claiming over one million American lives, exceeding Vietnam War casualties. This colossal policy failure has rightly been labelled a "national disgrace" by reform advocates across the political spectrum.

Revelations of calculated choices sparking this crisis spotlight the corrosive influence of moneyed interests on governing institutions. The opioid epidemic illustrates how profit motives can capture regulators and corrupt policy to enrich a privileged few at monstrous public expense. The outsized lobbying power of opioid makers won them effective impunity while stifling reforms, allowing intended consequences to unfold.

Industry players secured enablers at the highest levels through strategic donations to politicians, advocacy groups, and regulators seeking influence. Opiate makers like Purdue lavished millions on contributions and lobbying funds to shape policy responses amenable to their bottom lines. Many lawmakers pursuing opioid deregulation were themselves among the biggest recipients of pharma cash, raising conflict of interest questions.

The notorious "revolving door" between regulators and regulated further entwined public agencies with opioid corporate interests. Several senior DEA officials involved in drug policy oversight have since joined opioid makers they once regulated, or defend them as lobbyists.

Such relationships inevitably raise doubts over whose interests the governing institutions truly serve under the capture of moneyed influences. Does the inordinate access and power of corporate lobbies undermine regulatory missions by corrupting public servants into servants of industry? Have democratic ideals of responsive leadership devolved into a system rigged by elite influence networks and tycoons? The tragic arc of the opioid crisis lends credence to critiques of America as a plutocracy masquerading as a republic.

As the opioid catastrophe escalated, responses from political leaders long paid to ignore warning signs ranged from tepid to complicit. Despite constituencies being decimated, many avoided policies that could curb profits, like prosecuting company leaders or funding treatment. Belated emergency decrees provided cover while avoiding real accountability. Opioid makers still reap billions in profits after paying settlements trivial relative to the scale of harms inflicted.

This sordid history raises skepticism about entrusting crisis response solely to the perpetrators and enablers who incubated the epidemic. Their pledges to make amends now ring hollow absent owning responsibility. Meaningful reforms appear necessary to constrain corporate power and corrupt elite influence that subordinate public welfare to private interests. Americans shaken by this nightmarish episode may conclude the institutions are too compromised to self-correct and must be redeemed through progress over plutocracy.

The merciless human toll of America's opioid plague spotlights endemic corruption of governing systems by moneyed special interests. This ongoing public health disaster was spawned by the callous pursuit of profit, enabled by regulatory surrender in the face of lobbying might. The scheme engorged the coffers of opioid makers while crushing families, communities, and faith in leaders. Its immense costs lay bare the moral bankruptcy of institutions serving the privileged few at such grievous public expense.

Redeeming civic promise requires truth, justice and change. The powerful must be held to account, balance restored to governance, and public interest reinstalled over private enrichment. For generations, the opioid crisis will be remembered as either the nadir spurring renewal, or another chapter of eroding trust as elites escape consequences. Its lessons must shape the necessary reckoning ahead to reclaim democracy from moneyed interests and reaffirm that all lives matter over lobbyists. In such a colossal crisis and tragedy, any attempt to shift blame onto others is an unforgivable crime of deceiving the American people.

The author is a Beijing-based commentator. The views don't necessarily reflect those of China Daily.

If you have a specific expertise, or would like to share your thought about our stories, then send us your writings at opinion@chinadaily.com.cn or comment@chinadaily.com.cn.

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    精品国产免费一区二区三区香蕉| 久久综合精品国产一区二区三区| 一级日本不卡的影视| 欧美性猛交一区二区三区精品| 亚洲国产婷婷综合在线精品| 欧美电影在哪看比较好| 韩国av一区二区| 欧美国产日韩精品免费观看| 99国产精品一区| 亚洲国产你懂的| 日韩三级伦理片妻子的秘密按摩| 国产乱码字幕精品高清av| 国产精品色呦呦| 欧美日韩一区二区三区免费看 | 欧美三级视频在线播放| 免费高清不卡av| 欧美极品aⅴ影院| 91国在线观看| 久久成人麻豆午夜电影| 国产精品对白交换视频 | 欧美视频一二三区| 蓝色福利精品导航| 国产精品丝袜久久久久久app| 欧美在线观看视频在线| 久久国产精品色| 国产精品污网站| 欧美久久久久久蜜桃| 国产激情视频一区二区在线观看 | 国产白丝精品91爽爽久久| 一区二区三区在线视频免费 | 成人精品免费看| 亚洲一区国产视频| 欧美精品一区二区三区四区| 99国产精品久久久久| 三级欧美韩日大片在线看| 久久久高清一区二区三区| 色婷婷久久久综合中文字幕 | 色噜噜狠狠色综合欧洲selulu| 免费国产亚洲视频| 中文字幕中文字幕在线一区 | 亚洲欧美激情一区二区| 欧美一级精品大片| 99久久精品99国产精品| 麻豆精品一区二区综合av| 亚洲欧洲色图综合| 欧美大片在线观看一区| 91污片在线观看| 国产一区二区主播在线| 亚洲午夜国产一区99re久久| 26uuu亚洲综合色欧美| 欧美午夜精品电影| 成人蜜臀av电影| 麻豆精品一区二区综合av| 一区二区三区欧美日| 久久久久9999亚洲精品| 欧美美女黄视频| 99久久精品免费看国产免费软件| 美国十次综合导航| 亚洲成人在线观看视频| 国产精品久久夜| 久久综合视频网| 51久久夜色精品国产麻豆| 色综合久久中文字幕综合网| 国产精品一区二区你懂的| 日本不卡123| 亚洲国产中文字幕在线视频综合| 国产精品久久久久久久久快鸭 | 久久夜色精品国产噜噜av| 欧美日韩日日骚| 91麻豆成人久久精品二区三区| 国产精品一级片在线观看| 日韩一区欧美二区| 亚洲国产综合在线| 亚洲三级免费电影| 国产精品视频你懂的| 久久综合九色综合欧美就去吻 | 极品美女销魂一区二区三区 | 国产精品无码永久免费888| 精品国产区一区| 91精品国产综合久久久久久久| 91黄视频在线| 一本大道久久a久久精二百| 国产精品天干天干在线综合| 久久嫩草精品久久久精品一| 欧美色综合网站| 91亚洲精品久久久蜜桃| 懂色一区二区三区免费观看| 国产在线播放一区三区四| 久久av老司机精品网站导航| 免费视频一区二区| 日本亚洲天堂网| 日韩精品亚洲一区二区三区免费| 亚洲电影在线播放| 亚洲一区二区三区国产| 亚洲色图视频网| 亚洲日本va在线观看| 综合自拍亚洲综合图不卡区| 国产精品免费久久| 国产精品久久看| 最新国产の精品合集bt伙计| 中文字幕av不卡| 中文字幕一区日韩精品欧美| 国产精品久久久久aaaa樱花| 国产精品福利一区二区| 亚洲婷婷国产精品电影人久久| 中文字幕日韩一区| 亚洲精品乱码久久久久久久久| 亚洲精品视频一区| 亚洲午夜在线电影| 午夜电影一区二区| 日韩成人精品视频| 久久不见久久见免费视频1 | 奇米色一区二区三区四区| 日本视频一区二区| 蜜臀久久99精品久久久画质超高清| 日本欧美一区二区三区乱码 | 美脚の诱脚舐め脚责91 | 在线观看国产一区二区| 在线亚洲人成电影网站色www| 欧美主播一区二区三区| 欧美日韩国产综合视频在线观看| 欧美年轻男男videosbes| 日韩欧美在线123| 久久亚洲二区三区| 国产精品久久久99| 一区2区3区在线看| 免费成人性网站| 国产成人午夜99999| aa级大片欧美| 欧美日韩中文国产| 精品久久久久av影院| 国产欧美日韩麻豆91| 亚洲色图第一区| 五月天久久比比资源色| 久久97超碰国产精品超碰| 大桥未久av一区二区三区中文| 99re热这里只有精品视频| 欧美日韩在线播放三区| 精品电影一区二区| 国产精品国产三级国产a| 亚洲综合激情网| 免播放器亚洲一区| 波多野结衣中文字幕一区二区三区| 色屁屁一区二区| 欧美一区二区福利视频| 久久久国产精品麻豆| 亚洲乱码国产乱码精品精的特点| 日韩国产在线一| 国产乱妇无码大片在线观看| 色综合天天在线| 欧美一区二区久久久| 国产精品美女久久久久久久久| 亚洲制服欧美中文字幕中文字幕| 麻豆高清免费国产一区| 成人午夜伦理影院| 欧美日韩亚洲另类| 久久久99免费| 亚洲国产精品久久不卡毛片| 韩国一区二区三区| 欧美优质美女网站| 久久无码av三级| 亚洲一区二区三区视频在线| 黑人巨大精品欧美一区| 在线免费观看日韩欧美| 久久综合狠狠综合久久激情 | 丝袜a∨在线一区二区三区不卡| 国产成人亚洲精品狼色在线| 欧美日韩在线一区二区| 国产精品网站在线| 蜜臀久久99精品久久久画质超高清| 成人激情视频网站| 欧美一区二区啪啪| 亚洲精品亚洲人成人网| 国产真实乱偷精品视频免| 欧美影院一区二区| 欧美国产日韩在线观看| 奇米一区二区三区| 色噜噜久久综合| 国产欧美日韩综合| 秋霞电影一区二区| 日本久久电影网| 日本一区二区三区在线不卡| 视频一区二区三区在线| 91在线你懂得| 久久久久久久电影| 日本最新不卡在线| 欧美亚洲图片小说| 国产精品电影院| 国产精一区二区三区| 欧美巨大另类极品videosbest | 日本福利一区二区| 亚洲国产精品99久久久久久久久 | 国产成人精品三级| 欧美一区三区二区| 亚洲一区av在线| 不卡的av在线| 久久精品人人做人人综合| 日本午夜一区二区| 欧美日韩另类国产亚洲欧美一级| 国产精品国产自产拍高清av|